| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 4,032 | 5,045 | 141,175 | 97,790 | | Cost of Revenue | 11,303 | 17,499 | 84,808 | 19,258 | | | Gross Profit | (7,271) | (12,454) | 56,367 | 78,532 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,185 | 16,726 | (19,101) | 36,819 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,709 | 3,325 | 3,505 | 3,296 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (28,165) | (32,505) | 71,963 | 38,417 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 633 | 598 | 317 | 454 | | Earnings Before Interest And Taxes | (27,532) | (31,907) | 72,280 | 38,871 | | Interest Expense | 5,408 | 5,029 | 3,155 | 4,197 | | Income Before Tax | (32,940) | (36,936) | 69,125 | 34,674 | | Income Tax Expense | (13,462) | (15,096) | 27,822 | 13,763 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (19,478) | (21,840) | 41,303 | 20,911 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (19,478) | (21,840) | 41,303 | 20,911 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($19,478) | ($21,840) | $41,303 | $20,911 |
|
0.04% Nasdaq 
Income Statement
